Colorectal Cancer Clinical Trials in Pittsburgh

Showing 141-160 of 169 trials

Safety Study of Modified Vaccinia Virus to Cancer

NCT00574977

The purpose of this study is to determine the safety and maximum tolerated dose from injecting this vaccinia virus into tumors or infusion.

MelanomaBreast CancerHead and Neck Squamous Cell Cancer+3 more

David Bartlett26 participantsStarted May 2008

Pittsburgh, Pennsylvania, United States

COMPLETEDPHASE3< 1 mile

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

NCT00075868

RATIONALE: Octreotide may be effective in preventing or controlling diarrhea in patients who are undergoing chemoradiotherapy for anal or rectal cancer. It is not yet known whether octreotide is effective in treating diarrhea. PURPOSE: This randomized phase III trial is studying octreotide in preventing or reducing diarrhea in patients who are undergoing chemoradiotherapy for anal or rectal cancer.

Anal CancerColorectal CancerDrug/Agent Toxicity by Tissue/Organ+1 more

Radiation Therapy Oncology Group233 participantsStarted Dec 2003

Mobile, Alabama, United States • Phoenix, Arizona, United States • Chico, California, United States +109 more locations

Safety Study of Modified Vaccinia Virus to Cancer

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Colorectal Cancer Trials in Other Cities

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

Other Conditions in Pittsburgh